Physician profile
Jonathan K Arad
NPI 1104090901
$2,631.20
in general payments reported to CMS, 2019-2025
10 companies · $36.49 in 2025
The $36.49 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,393 · 2020: $91.43 · 2021: $170 · 2023: $258 · 2024: $682 · 2025: $36.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $823 · Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $823.06 |
| Food and Beverage | $153.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,114.12 | 2019 | |
| Curonix LLC | $890.70 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Lucid Diagnostics INC. | $145.44 | 2021 | |
| Novo Nordisk INC | $114.49 | 2019-2021 | |
| Apollo Endosurgery US INC | $108.75 | 2019 | |
| Vertiflex, INC. | $99.99 | 2019 | |
| Boston Scientific Corporation | $44.91 | 2024-2025 | Varithena Administration Pack, Ams 700 |
| Endo Pharmaceuticals INC. | $41.93 | 2020 | |
| Abbvie INC. | $40.89 | 2024-2025 | |
| Venclose INC. | $29.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Arad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.